Skip to main content
SpringerLink
Log in

Invasive Fungal Infections

  • Chapter
  • First Online:
Management of Antimicrobials in Infectious Diseases

Part of the book series: Infectious Disease ((ID))

  • 1715 Accesses

Abstract

The incidence of invasive fungal infections in immunocompetent and immunocompromised patients has increased significantly over the last decade. Candidemia has been identified as the fourth most common nosocomial bloodstream infection in the United States. Geographically, endemic mycoses continue to be a source of morbidity and mortality. With a number of treatment options and increasing incidence of resistance, clinicians must understand the unique aspects of each pathogen and the strengths of each medication in order to choose the appropriate therapeutic strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Edmond MB, Wallace SE, McClish DK et al. (1999). Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 29:239–244

    Article  PubMed  CAS  Google Scholar 

  2. Forrest GN, Mankes K, Jabra-Rizk MA et al. (2006). Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 44:3381–3383

    Article  PubMed  CAS  Google Scholar 

  3. Ryan KJ, Ray CG (eds) (2004). Sherris medical microbiology: An introduction to infectious diseases, 4th ed. New York: McGraw Hill

    Google Scholar 

  4. Beck-Sagué CM, Jarvis WR (1993). Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis 167:1247–1251

    Article  PubMed  Google Scholar 

  5. Pfaller MA, Diekema DJ, Jones RN et al.; SENTRY Participants Group (2002). Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 40:852–856

    Article  PubMed  CAS  Google Scholar 

  6. Pfaller MA, Jones RN, Doern GV et al. (1999). International surveillance of blood stream infections due to Candida species in the European SENTRY program: Species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn Microbiol Infect Dis 35:19–25

    Article  PubMed  CAS  Google Scholar 

  7. Diekema DJ, Messer SA, Brueggemann AB et al. (2002). Epidemiology of candidemia: Three-year results from the emerging infections and the epidemiology of lowa organisms study. J Clin Microbiol 40:1298–1302

    Article  PubMed  CAS  Google Scholar 

  8. Ristow KL, Schreckenberger PC, Danziger LH (2002). Epidemiology of Candida bloodstream infections in the intensive care unit. In: Program and abstracts of Focus on Fungal Infections 12, Phoenix, AZ, March 20–22, 2002. Alpharetta, GA: Imedex® 7 abstract

    Google Scholar 

  9. Eilard T (1987). Isolation of fungi in blood cultures. A review of fungal infections in the western part of Sweden 1970–1982. Scand J Infect Dis 19:145–156

    Article  PubMed  CAS  Google Scholar 

  10. Lin SJ, Schranz J, Teutsch SM (2001). Aspergillosis case-fatality rate: Systematic review of the literature. Clin Infect Dis 32:358–366

    Article  PubMed  CAS  Google Scholar 

  11. Laine L, Dretler RH, Conteas CN et al. (1992). Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS: A randomized trial. Ann Intern Med 117:655–660

    PubMed  CAS  Google Scholar 

  12. Louie L, Ng S, Hajjeh R et al. (1999). Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis 5:672–680

    Article  PubMed  CAS  Google Scholar 

  13. Chapman SW, Bradsher RW, Campbell GD (2000). Practice guidelines for the management of patients with blastomycosis. Clin Infect Dis 30:679–683

    Article  PubMed  CAS  Google Scholar 

  14. MacDougall L, Kidd SE, Galanis E et al. (2007). Spread of Cryptococcus gattii in British Columbia, Canada and detection in the Pacific Northwest, USA. Emerg Infect Dis 13:42–50

    Article  PubMed  Google Scholar 

  15. Pascual AA, Bolay S, Marchietti O (2006). Documentation of low voriconazole blood levels followed by dose adjustment in patients with invasive fungal infections not responding to therapy (abstract M-1304). Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27–30, 2006. San Francisco, California

    Google Scholar 

  16. Khoo SH, Bond J, Denning DW (1994). Administering amphotericin B – a practical approach. J Antimicrob Chemother 33:203–213

    Article  PubMed  CAS  Google Scholar 

  17. Ellis ME, Al-Hokail AA, Clink HM et al. (1992). Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B. Antimicrob Agents Chemother 36:172–179

    PubMed  CAS  Google Scholar 

  18. Wingard JR, Kubilis P, Lee L et al. (1999). Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 29: 1402–1407

    Article  PubMed  CAS  Google Scholar 

  19. Rex JH, Rinaldi MG, Pfaller MA (1995). Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39:1–8

    PubMed  CAS  Google Scholar 

  20. Nguyen MH, Peacock JE, Jr., Morris AJ et al. (1996). The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am J Med 100: 617–623

    Article  PubMed  CAS  Google Scholar 

  21. Cordonnier C, Bresnik M, Ebrahimi R (2007). Liposomal amphotericin B (AmBisome®) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: A pooled analysis. Mycoses 50:205–209

    Article  PubMed  CAS  Google Scholar 

  22. Herbrecht R, Denning DW, Patterson TF et al. (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415

    Article  PubMed  CAS  Google Scholar 

  23. Marr KA (2008). Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: Clinical implications of recent studies. Curr Opin Infect Dis 21:409–414

    Article  PubMed  Google Scholar 

  24. Cornely OA, Maertens J, Winston DJ et al. (2007). Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348–359

    Article  PubMed  CAS  Google Scholar 

  25. Walsh TJ, Raad I, Patterson TF et al. (2007). Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial. Clin Infect Dis 44:2–12

    Article  PubMed  CAS  Google Scholar 

  26. Maertens J, Raad I, Petrikkos G et al. (2004). Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 39:1563–1571

    Article  PubMed  CAS  Google Scholar 

  27. Marr KA, Boeckh M, Carter RA et al. (2004). Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 39:797–802

    Article  PubMed  CAS  Google Scholar 

  28. Stevens DA, Rendon A, Gaona-Flores V et al. (2007). Posaconazole therapy for chronic refractory coccidioidomycosis. Chest 132:952–958

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious and Immunologic Diseases, School of Medicine, University of California Davis, Sacramento, CA, USA

    Javeed Siddiqui

Authors
  1. Javeed Siddiqui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javeed Siddiqui .

Editor information

Editors and Affiliations

  1. Dept. Family Medicine, Medical University of South Carolina, Calhoun St. 295, Charleston, 29425, U.S.A.

    Arch G. Mainous III

  2. School of Medicine, University of California, Davis, Davis, 95616, U.S.A.

    Claire Pomeroy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Siddiqui, J. (2010). Invasive Fungal Infections. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-239-1_7

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-238-4

  • Online ISBN: 978-1-60327-239-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation